Opinion of the President – treatment of mucopolysaccharidosis type II (Hunter syndrome)
On 10 February 2025, the President of the Agency for Health Technology Assessment and Tariff System issued opinion No. 11/2025 on the appropriateness of introducing changes to the drug program B.25 Treatment of mucopolysaccharidosis type II (Hunter syndrome) (ICD-10 E76.1)